Giving a non-auto injector to someone who has anaphalyactic shock occurring sounds fun, especially with a small child. The FDA Access data
makes it clear that the syringe is totally exposed from the initial dose/entry. Have fun "slowly" inserting Symjepi into your child's thigh... (or your own!)
Non-autoinjector means there's also a bigger accidental prick/injection in unintended body part risk both before and after injection (especially after - EpiPen orange cap moves to cover needle as it is removed and Auvi-Q auto retracts).
Curious to see what the price point will be on Symjepi, it may help put downward price pressure on everything else if it's cheap enough.
Case looks big as does autoinjector, but without scale (they say the syringe fits in the palm of an adult) it's hard to gauge.
I think
Windgap Medical's version of an autoinjector holds the most promise, if it can make it to market (they hope to apply to FDA in 2018). It's solid until the cap is removed, at which point the solution rehydrates to a solid. Meaning it tolerates a lot more temperature/handling conditions than liquid epinephrine in something "the size of a roll of quarters", with a much longer lifespan than liquid epinephrine too (years, not a year).